Related Experiment Videos
Analysis of P-glycoprotein expression in osteosarcoma
M Serra1, K Scotlandi, M C Manara
1Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli, Bologna, Italy.
European Journal of Cancer (Oxford, England : 1990)
|November 1, 1995
Summary
P-glycoprotein overexpression in osteosarcoma indicates potential multidrug resistance and a higher relapse rate. This finding may help predict treatment outcomes for patients with this aggressive bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- High-grade osteosarcoma treatment relies on surgery and chemotherapy.
- Multidrug resistance is a significant challenge in osteosarcoma treatment.
- P-glycoprotein is a key marker associated with multidrug resistance.
Purpose of the Study:
- To investigate the role of P-glycoprotein expression in osteosarcoma.
- To determine if P-glycoprotein can predict chemotherapy resistance and patient outcomes.
Main Methods:
- Evaluated P-glycoprotein expression in 105 osteosarcoma cases using semiquantitative immunofluorescence.
- Utilized multidrug-resistant osteosarcoma cell lines as standards.
- Correlated P-glycoprotein levels with treatment response and relapse rates in 38 homogeneously treated patients.
Main Results:
- P-glycoprotein overexpression was observed in 23% of primary and 50% of metastatic osteosarcoma lesions.
- Overexpression was associated with a higher relapse rate.
- A trend towards a worse outcome was noted in patients with P-glycoprotein overexpression.
Conclusions:
- P-glycoprotein expression is a significant factor in osteosarcoma chemotherapy response.
- P-glycoprotein may serve as a predictive marker for patient outcomes in osteosarcoma.
- Targeting P-glycoprotein could potentially improve treatment strategies for osteosarcoma.